ARC Group Acquisition II, a newly formed blank check company targeting businesses in technology, healthcare and logistics, has filed with the SEC to raise up to $105 million in an initial public offering. The proposed Nasdaq listing adds another SPAC to an increasingly active pipeline of acquisition vehicles seeking opportunities across high-growth sectors.

Company Background

ARC Group Acquisition II is a special purpose acquisition company, or SPAC, established to identify and complete a business combination with a target company. Its stated focus includes the technology, healthcare and logistics industries.

The Tempe, Arizona-based company was founded in 2025 and is led by an executive team with backgrounds in business development, investment banking and capital markets.

CEO Jonathan Jaranilla serves as Head of Business Development and Investor Relations at Exascale Labs, which has a pending merger with BCAR. CFO Jake Carney is a former Managing Director at ARC Group, while COO and Director Ian Hanna is CEO and Partner of ARC Group Securities.

The new SPAC is part of a broader group of affiliated vehicles associated with ARC Group. ARC Group Acquisition I (ARCLU) raised $105 million in April, while ARC Group Securities Acquisition I (FJDIU) raised $105 million earlier this month. ARC Group Securities Acquisition II (WECOU) has also filed to raise $105 million.

The concentration of affiliated SPAC activity indicates an ongoing effort by the ARC Group network to build multiple acquisition vehicles across the public markets.

IPO Details

ARC Group Acquisition II plans to raise $105 million by offering 10.5 million units at $10 each.

Each unit is expected to consist of one share of common stock, one warrant exercisable at $11.50 per share, and one-quarter of a right to receive a share upon completion of a business combination.

The company plans to list on the Nasdaq under the proposed ticker symbol CLMZU.

Arc Group Securities is serving as the sole bookrunner for the offering.

The filing represents a proposed IPO rather than a completed transaction, meaning the final terms, timing and other offering details could change before the deal closes.

Market Context & Opportunities

The SPAC structure provides sponsors with capital to pursue acquisitions without identifying a target company before the IPO. Once public, the vehicle typically has a defined period in which to identify a suitable acquisition target and obtain shareholder approval for a business combination.

ARC Group Acquisition II’s focus on technology, healthcare and logistics places it across several sectors where businesses can benefit from digitalization, changing consumer and enterprise demand, and continued investment in infrastructure and technology.

Technology companies can offer exposure to software, artificial intelligence and other emerging platforms, while healthcare provides access to businesses operating across medical services, biotechnology and healthcare technology. Logistics similarly remains connected to the growth of e-commerce, supply-chain modernization and technology-enabled transportation.

The company’s sponsor network may also provide an established capital-markets and deal-making infrastructure as it searches for a potential target.

Risks & Challenges

As with other SPACs, the primary challenge will be identifying an acquisition target that can justify the capital raised and ultimately create value for shareholders.

The company has not yet identified a target, so investors currently have limited visibility into the eventual operating business. The performance of the eventual combination will depend heavily on the quality, valuation and growth prospects of the company ultimately selected.

Competition among SPACs can also make attractive acquisition targets difficult to secure. Technology, healthcare and logistics companies may attract interest from strategic buyers, private-equity firms and other acquisition vehicles.

There are also structural considerations associated with warrants and rights. Future exercises and share issuance can result in dilution for existing shareholders depending on the terms of the eventual business combination.

Closing Outlook

ARC Group Acquisition II’s proposed $105 million IPO expands the ARC Group network’s growing presence in the SPAC market while targeting three broad sectors with significant technology and investment activity.

The immediate question is whether the sponsor team can convert its capital-markets experience and sector focus into a compelling acquisition. Until a target is identified, CLMZU remains primarily a vehicle for future deal-making rather than an investment in an operating company. Its eventual appeal will therefore depend on the quality of the business ARC Group Acquisition II ultimately brings to the public market.